Samsara BioCapital

The journey from discovery to medical breakthrough demands imagination, speed, and focus. At Mission BioCapital, we provide early-stage capital to the next generation of awesome life science entrepreneurs and the platform where they can realize their visions. This approach has revolutionized the way life science start-ups progress from idea to key data through a model that champions collaboration at the center of everything we do. Our team has a deep-rooted commitment to empowering exceptional life science entrepreneurs from all walks of life. From your first experiment in our shared lab space through to the clinic, we want to be your partner in accelerating development of scientific solutions – faster, focused and more efficiently – to individuals and communities in most need. We’re there, from idea to exit. We are scientists, investors, founders, and serial entrepreneurs. Our team has a long history together, investing in, launching, and building dozens of early-stage life science companies. Making Transformational Investments. Founded in 2009, we are now investing out of our fifth fund. Since our inception, we have invested in early-stage life science companies following the same core principles: Mentorship and Collaboration – within our team and with founders Innovation and Creativity – in how we structure our investments and find solutions to problems; we are entrepreneurs too! Respect and Support – for the founders we work with

Headquartered in Silicon Valley, H7 BioCapital is a global venture platform that supports the transformational growth of healthcare companies through its influential venture capital financing, global accelerator program, venture club, VC class, webinars, conferences and other strategic events, and connect them with investors, scientists, physicians, corporate partners and other industrial professionals to jointly build a resource - rich healthcare innovation ecosystem. H7 BioCapital consists of three parts of organizations: H7 Accelerator, H7 Venture, and H7 Café to support the transformational growth of healthcare by striving to be transformational itself. Need a boost with your healthcare startup? Let H7 be your support - Health, Heal, Happiness, Hope, Humanity, Home and Holistic! H7 Accelerator 3-month-long cohort-based healthcare accelerator program providing mentorship, funding and other support to early-stage biotech, medtech and device startups along with a lifelong network for these leaders and innovators. H7 Venture Investment platform providing early stage funding support to healthcare startups that are believed to have a long-term growth potential. H7 Café A high-quality startup community that supports the growth of healthcare entrepreneurs by frequent events such as networking, educational workshop, private deal flow meetings and other programs to connect the corporate, scientists, investor and founder ecosystem.

HealthCap is a European venture capital firm investing exclusively and globally in life sciences. The investment strategy focuses on diseases with high unmet medical needs and breakthrough therapies that have the potential to be transformative and change medical practice, and the lives of patients suffering these conditions. Having raised more than EUR 1.2 billion since 1996, HealthCap has backed and built more than 125 companies, taken more than 45 companies public and done numerous trade sales. Over the years, HealthCap companies have developed more than 25 pharmaceutical products to market approval, many of which are breakthrough therapies helping patients with life-threatening diseases. In addition, HealthCap companies have brought more than 50 innovative medical device products to market. These products have generated significant value to many stakeholders, including patients, physicians and society, and as a result also to HealthCap investors.

We are a European family office owned fund; we understand biosciences and medical technologies better than anyone else in the Private Equity and Venture Capital ecosystem. The capital of this fund has been generated by the family office's active bioscience investments across Europe, USA, and the APAC region since 1995. We understand the intricacies of commercializing bioscience discoveries. We also acknowledge that bioscience venture leadership requires deep courage - from founders and the investors that back them. What we look for We operate globally and only review investment opportunities submitted to us by our partner investment banks across the globe. If we believe in the transformative power of the discovery and the founder's ambition, this will suffice for us to determine the venture's potential. Our approach Upon receipt of a proposal from our investment bank partners, we will analyze the proposed deal, meet with the venture founders, and understand their vision. We will propose a deal size and structure. Execute a letter of intent and perform appropriate due diligence, negotiate, and execute a mutually acceptable binding contract. Release the required funding, close the transaction and work together to grow the business.

LemVega Capital is a prestigious and elite investment management firm providing investment advisory services and three unique funds to ultra-high-net-worth individuals and institutions. Our firm was established with the objective of assisting investors in achieving their financial goals by offering access to alternative investment opportunities that are typically not available through traditional channels. Headquartered in Puerto Rico and the United States, LemVega Capital™ is registered as an exempt-reporting adviser and is recognized as a distinguished financial institution. As a multi-fund, multi-generational firm, we operate three funds under management, collectively managing a substantial eight-figure assets under management (AUM). Our fund offerings include two cutting-edge hedge funds and an innovative biotech venture capital fund. As a leading firm, LemVega Capital™ leverages advanced technology and time-tested investment strategies to deliver remarkable returns for our clients. Our portfolio comprises a diverse range of investments, including equities, derivatives, currencies, commodities, and groundbreaking biotech offerings. With our unique position as a long & short multi-strategy asset hedge fund, we employ both technical and fundamental analysis, giving us a competitive edge in making astute investment decisions. At the heart of LemVega Capital™, we prioritize transparency, integrity, and delivering results. Our seasoned team of professionals possesses a deep understanding of financial markets and is dedicated to upholding the highest standards of excellence. We have implemented a robust risk management framework to safeguard our clients' capital under all circumstances. Whether you are an institutional investor or a high-net-worth individual, LemVega Capital™ offers a distinctive and compelling investment proposition. Our combination of innovative investment strategies and unwavering commitment to our clients sets us apart in the finance industry.

Since its genesis at the University of Oxford in 2015, Panacea Innovation has partnered with some of the world’s best sci-entrepreneurs, research bodies, universities and corporates to build more than 280 companies that offer cutting-edge solutions - curating a portfolio of more than GBP£300m in value. Panacea Innovation’s venturing activities are delivered through two complementary arms: Panacea Stars - a technology translation, commercialisation and R&D arm - and Panacea Ventures, the investment management one.